combination data is nonexistent Safety first Overlapping side effect profiles create legitimate concerns about additive adverse events Patience pays Phase 3 trials for both compounds are ongoing
Pharmaceutical companies are creating even more potent weight-loss medications by targeting multiple gut hormone receptors at once
In vivo data were analysed with a two-way ANOVA followed by Tukeys post-hoc test (fasted glucose levels, ipGTT glucose excursion, body weight and food intake) or a one-way ANOVA followed by Dunnetts or Tukeys post-hoc test (glucose AUC, terminal fat and clinical chemistry data)
These drugs work by reducing the passing of stool through your digestive system
If a double chin is your concern, it is also worth discussing alternatives such as HIFU at consultation, so you choose the approach that genuinely fits your anatomy and goals
Perhaps the answer is to hit hard for several days three or four times a year, says Horowitz